The Use of Credit Ratings in the Delegated Management of Fixed Income Assets
Management Science · 2024-05 · 70 (5) · 3059-3079
DOI: 10.1287/mnsc.2023.4848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Management Science, 2024-05. Verfasst von Ramin P. Baghai und 2 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Investment mandates of fixed income funds constrain managers’ portfolio decisions, often employing credit ratings to classify asset risk. We categorize U.S. and European fixed income funds’ mandates using textual analysis and measure the use of ratings. Over the past two decades, despite the weaknesses of ratings revealed in the global financial crisis, ratings use has increased significantly. Since 2010, the fraction of funds not using ratings in any way has fallen by almost half in both the United States and Europe. By 2020, 94% of U.S. funds and 65% of European funds used ratings. These patterns fit agency-based models of investment mandates and point to a lack of practically useful alternatives. This paper was accepted by Tomasz Piskorski, finance. Funding: This work was supported by the Nasdaq Nordic Foundation. Supplemental Material: The data files and e-companion are available at https://doi.org/10.1287/mnsc.2023.4848 .
Zitieren
APA
Baghai, R. P., Becker, B., & Pitschner, S. (2024). The Use of Credit Ratings in the Delegated Management of Fixed Income Assets. Management Science, 70(5), 3059-3079. https://doi.org/10.1287/mnsc.2023.4848
Vancouver
Baghai RP, Becker B, Pitschner S. The Use of Credit Ratings in the Delegated Management of Fixed Income Assets. Management Science. 2024;70(5):3059-3079. doi:10.1287/mnsc.2023.4848
BibTeX
@article{Baghai2024,
author = {Baghai, Ramin P. and Becker, Bo and Pitschner, Stefan},
title = {The Use of Credit Ratings in the Delegated Management of Fixed Income Assets},
journal = {Management Science},
year = {2024},
volume = {70},
number = {5},
pages = {3059--3079},
doi = {10.1287/mnsc.2023.4848}
}
EUVIMED